Ha habido 50 transacciones internas recientes registradas para Arcturus Therapeutics Holdings Inc. (ARCT), incluyendo 29 compras y 19 ventas. El total de compras internas fue valorado en $24.34M y el total de ventas internas en $5.5M.
Internos destacados con actividad reciente incluyen Payne Joseph E, Chivukula Pad, Kurata Lance. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ARCT
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-12-17 |
Payne Joseph E |
President and CEO |
Concesión de RSU |
175,000 |
$6.52 |
$1.14M |
175,000 |
| 2025-12-17 |
Chivukula Pad |
Chief Scientific Officer & COO |
Concesión de RSU |
54,000 |
$6.52 |
$352.08K |
54,000 |
| 2025-12-17 |
Kurata Lance |
Chief Legal Officer |
Concesión de RSU |
54,000 |
$6.52 |
$352.08K |
54,000 |
| 2025-12-17 |
Roberts Joseph |
Controller |
Concesión de RSU |
10,000 |
$6.52 |
$65.2K |
10,000 |
| 2025-12-12 |
Roberts Joseph |
Controller |
Desconocido |
7,500 |
$28.88 |
$216.6K |
- |
| 2025-08-15 |
Sassine Andy |
Chief Financial Officer |
Venta Informativa |
1,238 |
$16.56 |
$20.5K |
221,764 |
| 2025-08-15 |
Sassine Andy |
Chief Financial Officer |
Compra Informativa |
1,238 |
$16.56 |
$20.5K |
221,764 |
| 2025-06-09 |
Farrell Peter C |
Director |
Concesión de RSU |
15,000 |
$12.54 |
$188.1K |
15,000 |
| 2025-06-09 |
Barlow James F |
Director |
Concesión de RSU |
15,000 |
$12.54 |
$188.1K |
15,000 |
| 2025-06-09 |
Holmes Edward W |
Director |
Concesión de RSU |
15,000 |
$12.54 |
$188.1K |
15,000 |
| 2025-06-09 |
Marquet Magda |
Director |
Concesión de RSU |
15,000 |
$12.54 |
$188.1K |
15,000 |
| 2025-06-09 |
Slaoui Moncef |
Director |
Concesión de RSU |
15,000 |
$12.54 |
$188.1K |
15,000 |
| 2025-06-09 |
Markels John |
Director |
Concesión de RSU |
15,000 |
$12.54 |
$188.1K |
15,000 |
| 2025-06-09 |
Marantz Jing L. |
Director |
Concesión de RSU |
15,000 |
$12.54 |
$188.1K |
15,000 |
| 2024-12-16 |
Sassine Andy |
Chief Financial Officer |
Concesión de RSU |
60,000 |
$16.24 |
$974.4K |
60,000 |
| 2024-12-16 |
Payne Joseph E |
President and CEO |
Concesión de RSU |
196,000 |
$16.24 |
$3.18M |
196,000 |
| 2024-12-16 |
Chivukula Pad |
Chief Scientific Officer & COO |
Concesión de RSU |
60,000 |
$16.24 |
$974.4K |
60,000 |
| 2024-12-16 |
Kurata Lance |
Chief Legal Officer |
Concesión de RSU |
60,000 |
$16.24 |
$974.4K |
60,000 |
| 2024-10-15 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
12,000 |
$20.76 |
$249.12K |
435,334 |
| 2024-06-19 |
Slaoui Moncef |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-06-19 |
Slaoui Moncef |
Director |
Concesión de RSU |
14,794 |
$25.96 |
$384.05K |
14,794 |
| 2024-06-14 |
Farrell Peter C |
Director |
Ejercicio de Opciones (Venta) |
3,131 |
- |
- |
- |
| 2024-06-14 |
Barlow James F |
Director |
Ejercicio de Opciones (Venta) |
3,131 |
- |
- |
- |
| 2024-06-14 |
Holmes Edward W |
Director |
Ejercicio de Opciones (Venta) |
3,131 |
- |
- |
- |
| 2024-06-14 |
Marquet Magda |
Director |
Ejercicio de Opciones (Venta) |
3,131 |
- |
- |
- |
| 2024-06-14 |
Markels John |
Director |
Ejercicio de Opciones (Venta) |
3,131 |
- |
- |
- |
| 2024-06-14 |
Marantz Jing L. |
Director |
Ejercicio de Opciones (Venta) |
3,131 |
- |
- |
- |
| 2024-06-12 |
Sassine Andy |
Chief Financial Officer |
Venta Informativa |
50,000 |
$32.03 |
$1.6M |
220,526 |
| 2024-06-05 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
114 |
$45.00 |
$5.13K |
447,334 |
| 2024-06-03 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
26,000 |
$40.01 |
$1.04M |
447,448 |
| 2024-03-25 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
17,435 |
$35.02 |
$610.57K |
473,448 |
| 2024-03-19 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
8,565 |
$35.01 |
$299.84K |
490,883 |
| 2023-12-15 |
Sassine Andy |
Chief Financial Officer |
Concesión de RSU |
75,000 |
$28.88 |
$2.17M |
75,000 |
| 2023-12-15 |
Payne Joseph E |
President and CEO |
Concesión de RSU |
200,000 |
$28.88 |
$5.78M |
200,000 |
| 2023-12-15 |
Chivukula Pad |
Chief Scientific Officer & COO |
Concesión de RSU |
125,000 |
$28.88 |
$3.61M |
125,000 |
| 2023-12-15 |
Kummerfeld Keith C |
See Remarks |
Concesión de RSU |
30,000 |
$28.88 |
$866.4K |
30,000 |
| 2023-12-15 |
Kurata Lance |
Chief Legal Officer |
Concesión de RSU |
75,000 |
$28.88 |
$2.17M |
75,000 |
| 2023-11-01 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
5,000 |
$18.72 |
$93.6K |
499,448 |
| 2023-10-02 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
5,000 |
$25.61 |
$128.06K |
504,448 |
| 2023-09-01 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
5,000 |
$31.45 |
$157.26K |
509,448 |
| 2023-08-15 |
Sassine Andy |
Chief Financial Officer |
Concesión de RSU |
1,223 |
$17.37 |
$21.25K |
270,526 |
| 2023-08-01 |
Farrell Peter C |
Director |
Concesión de RSU |
3,131 |
- |
- |
3,131 |
| 2023-08-01 |
Barlow James F |
Director |
Concesión de RSU |
3,131 |
- |
- |
3,131 |
| 2023-08-01 |
Holmes Edward W |
Director |
Concesión de RSU |
3,131 |
- |
- |
3,131 |
| 2023-08-01 |
Marquet Magda |
Director |
Concesión de RSU |
3,131 |
- |
- |
3,131 |
| 2023-08-01 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
5,000 |
$34.91 |
$174.55K |
514,448 |
| 2023-08-01 |
Markels John |
Director |
Concesión de RSU |
3,131 |
- |
- |
3,131 |
| 2023-08-01 |
Marantz Jing L. |
Director |
Concesión de RSU |
3,131 |
- |
- |
3,131 |
| 2023-07-14 |
Chivukula Pad |
Chief Scientific Officer & COO |
Venta Informativa |
25,000 |
$35.01 |
$875.25K |
519,448 |
| 2023-07-14 |
Kummerfeld Keith C |
See Remarks |
Venta Informativa |
6,968 |
$35.00 |
$243.88K |
950 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
